Addison Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43.4K Sell
1,801
-33,801
-95% -$884K 0.02% 262
2026
Q1
$1,000K Sell
35,602
-608
-2% -$16.2K 0.22% 80
2025
Q4
$902K Sell
36,210
-837
-2% -$21.1K 0.2% 85
2025
Q3
$944K Buy
37,047
+423
+1% +$10.4K 0.22% 83
2025
Q2
$888K Buy
36,624
+1,571
+4% +$36.6K 0.22% 80
2025
Q1
$888K Buy
35,053
+1,097
+3% +$28.7K 0.24% 71
2024
Q4
$901K Sell
33,956
-18,282
-35% -$496K 0.25% 71
2024
Q3
$1.51M Buy
52,238
+41,668
+394% +$1.22M 0.42% 51
2024
Q2
$296K Buy
10,570
+1,992
+23% +$54.8K 0.1% 150
2024
Q1
$238K Sell
8,578
-744
-8% -$20.6K 0.08% 161
2023
Q4
$268K Buy
9,322
+970
+12% +$29.3K 0.1% 138
2023
Q3
$277K Buy
8,352
+803
+11% +$28.4K 0.13% 122
2023
Q2
$277K Sell
7,549
-416
-5% -$16.2K 0.14% 121
2023
Q1
$325K Buy
7,965
+24
+0.3% +$1.04K 0.18% 101
2022
Q4
$407K Sell
7,941
-1,657
-17% -$79.4K 0.24% 82
2022
Q3
$420K Sell
9,598
-109
-1% -$5.3K 0.26% 75
2022
Q2
$509K Buy
9,707
+324
+3% +$16.5K 0.31% 66
2022
Q1
$486K Buy
9,383
+1,506
+19% +$78.1K 0.27% 74
2021
Q4
$465K Buy
7,877
+3,674
+87% +$182K 0.29% 66
2021
Q3
$181K Buy
4,203
+38
+0.9% +$1.68K 0.15% 82
2021
Q2
$163K Buy
+4,165
New +$162K 0.13% 95
2020
Q4
$157K Buy
+4,265
New +$156K 0.15% 96

Other funds holding PFE

Addison Advisors's PFE Position: Q2 2026 in Review

Addison Advisors reduced its Pfizer (PFE) stake by 95% in Q2 2026, selling an estimated $884K and leaving 1,801 shares worth $43.4K. The position accounts for 0.02% of the portfolio, ranked #262.

Addison Advisors first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.51M in Q3 2024. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Addison Advisors held 1,801 shares of Pfizer worth $43.4K as of Q2 2026.
  • Addison Advisors sold 33,801 Pfizer shares in Q2 2026, an estimated $884K.
  • Pfizer made up 0.02% of Addison Advisors's portfolio in Q2 2026, its #262 holding.
  • Addison Advisors first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
  • Addison Advisors's Pfizer position peaked at $1.51M in Q3 2024.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Addison Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.